Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose

por Maki, Kevin C, McKenney, James M, Farmer, Mildred V, Reeves, Matthew S, Dicklin, Mary R
Publicado 2009

Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy

por Koren, Michael J., Kereiakes, Dean, Pourfarzib, Ray, Winegar, Deborah, Banerjee, Poulabi, Hamon, Sara, Hanotin, Corinne, McKenney, James M.
Publicado 2015

Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO...

por Cannon, Christopher P., Cariou, Bertrand, Blom, Dirk, McKenney, James M., Lorenzato, Christelle, Pordy, Robert, Chaudhari, Umesh, Colhoun, Helen M.
Publicado 2015

The Effects of Fenofibric Acid Alone and With Statins on the Prevalence of Metabolic Syndrome and Its Diagnostic Components in Patients With Mixed Dyslipidemia

por Bays, Harold E., Roth, Eli M., McKenney, James M., Kelly, Maureen T., Thakker, Kamlesh M., Setze, Carolyn M., Obermeyer, Katie, Sleep, Darryl J.
Publicado 2010

Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized tri...

por Toth, Peter P., Hamon, Sara C., Jones, Steven R., Martin, Seth S., Joshi, Parag H., Kulkarni, Krishnaji R., Banerjee, Poulabi, Hanotin, Corinne, Roth, Eli M., McKenney, James M.
Publicado 2016